Aspira Women's Health Inc. (AWH): Price and Financial Metrics

Aspira Women's Health Inc. (AWH): $3.43

0.07 (-2.00%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add AWH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#179 of 363

in industry

AWH Price/Volume Stats

Current price $3.43 52-week high $6.75
Prev. close $3.50 52-week low $2.31
Day low $3.30 Volume 24,700
Day high $3.51 Avg. volume 32,313
50-day MA $4.29 Dividend yield N/A
200-day MA $3.99 Market Cap 35.46M

AWH Stock Price Chart Interactive Chart >

AWH POWR Grades

  • Growth is the dimension where AWH ranks best; there it ranks ahead of 92.02% of US stocks.
  • AWH's strongest trending metric is Growth; it's been moving up over the last 160 days.
  • AWH ranks lowest in Momentum; there it ranks in the 7th percentile.

AWH Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for AWH is -13.93 -- better than just 1.14% of US stocks.
  • With a year-over-year growth in debt of -25.45%, ASPIRA WOMEN'S HEALTH INC's debt growth rate surpasses merely 12.81% of about US stocks.
  • In terms of volatility of its share price, AWH is more volatile than 92.45% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ASPIRA WOMEN'S HEALTH INC are WRAP, LIQT, ECOR, ASPN, and PLAB.
  • AWH's SEC filings can be seen here. And to visit ASPIRA WOMEN'S HEALTH INC's official web site, go to www.vermillion.com.

AWH Valuation Summary

  • In comparison to the median Healthcare stock, AWH's price/earnings ratio is 106.86% lower, now standing at -2.
  • Over the past 243 months, AWH's price/earnings ratio has gone up 5.2.

Below are key valuation metrics over time for AWH.

Stock Date P/S P/B P/E EV/EBIT
AWH 2023-12-29 4.6 -64.0 -2.0 -1.9
AWH 2023-12-28 4.6 -64.6 -2.0 -1.9
AWH 2023-12-27 4.2 -59.2 -1.9 -1.7
AWH 2023-12-26 3.8 -53.0 -1.7 -1.5
AWH 2023-12-22 3.3 -45.4 -1.4 -1.3
AWH 2023-12-21 2.9 -39.9 -1.3 -1.1

AWH Growth Metrics

    The year over year revenue growth rate now stands at 46.32%.
  • Its 4 year cash and equivalents growth rate is now at 2.98%.
  • Its 3 year price growth rate is now at -70.15%.
Over the past 33 months, AWH's revenue has gone up $3,344,000.

The table below shows AWH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 7.882 -32.758 -31.03
2022-06-30 7.476 -32.127 -36.179
2022-03-31 7.209 -32.313 -35.01
2021-12-31 6.812 -27.395 -31.662
2021-09-30 6.407 -24.503 -28.782
2021-06-30 5.98 -19.569 -23.362

AWH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AWH has a Quality Grade of F, ranking ahead of 4.5% of graded US stocks.
  • AWH's asset turnover comes in at 0.15 -- ranking 221st of 682 Pharmaceutical Products stocks.
  • CLSN, DRRX, and RVNC are the stocks whose asset turnover ratios are most correlated with AWH.

The table below shows AWH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.150 0.328 -20.812
2021-03-31 0.170 0.288 -20.376
2020-12-31 0.289 0.266 -41.375
2020-09-30 0.308 0.337 116.497
2020-06-30 0.339 0.313 48.442
2020-03-31 0.337 0.304 38.632

AWH Price Target

For more insight on analysts targets of AWH, see our AWH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $12.00 Average Broker Recommendation 1.25 (Strong Buy)

Aspira Women's Health Inc. (AWH) Company Bio


Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.


AWH Latest News Stream


Event/Time News Detail
Loading, please wait...

AWH Latest Social Stream


Loading social stream, please wait...

View Full AWH Social Stream

Latest AWH News From Around the Web

Below are the latest news stories about ASPIRA WOMEN'S HEALTH INC that investors may wish to consider to help them evaluate AWH as an investment opportunity.

Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024

AUSTIN, Texas, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that it will host a virtual R&D day featuring experts who will present the exciting progress of the company’s product pipeline on January 4, 2024 at 11:00 AM ET. To register, click here. Upcoming R&D Day: Aspira R&D Day: Updates on the Development of

Yahoo | December 19, 2023

Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

Aspira management will be available for meetings in San Francisco (January 8-10, 2024) AUSTIN, Texas, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that management will be available for partnering and institutional one-on-one meetings in San Francisco, during JP Morgan’s Healthcare Conference Week 2024. Nicole

Yahoo | December 14, 2023

New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT

New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10;30 PM PT Episode 537: 1). Reliance Global Group, Inc. (NASDAQ: RELI) (NASDAQ: RELIW) ($RELI) 2). Aspira Women's Health (NASDAQ: AWH) ($AWH) 3). Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) 4).The Business of Blockchain, 5).Sekur Private Data, Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0) (Sekur®) - https://www.newtothestreet.com/ NEW YORK, Dec. 08, 202

Yahoo | December 8, 2023

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT Episode 536: 1). - Reliance Global Group, Inc. (NASDAQ: RELI) (NASDAQ: RELIW) ($RELI) 2). Aspira Women's Health (NASDAQ: AWH) ($AWH) 3). Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) 4). The Business of Blockchain 5).Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) (Sekur®) - https://www.ne

Yahoo | December 7, 2023

Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis

Data supports EndoCheck™ to be the first blood test for the identification of localized endometriosis, including endometrioma Platform migration to begin on the Company’s EndoMDx™ test for broader endometriosis indications AUSTIN, Texas, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that it has completed the de

Yahoo | December 6, 2023

Read More 'AWH' Stories Here

AWH Price Returns

1-mo -15.31%
3-mo -15.93%
6-mo -36.01%
1-year -36.88%
3-year -96.52%
5-year -80.12%
YTD -15.93%
2023 -18.22%
2022 -81.21%
2021 -73.62%
2020 728.40%
2019 170.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!